Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression

Accurate prediction of which patients with mild cognitive impairment (MCI) will progress to dementia remains a major challenge. Current biomarkers detect amyloid pathology with high accuracy but offer limited prognostic value for disease progression. We conducted a prospective analysis in the multic…

View Post on Scour ↗

More from Nature on Scour.